Pfizer has made significant progress in addressing some of its challenges. However, the company stil

Pfizer (PFE +0.07%) has experienced unprecedented circumstances in the previous decade.

They have a knack for increasing their dividends even when facing challenges.

Pfizer's free cash flow is not covering its dividend, and the company faces a patent cliff. Energy T

European committee backs Merck's Keytruda + Padcev combo for bladder cancer after Phase 3 trial

Pfizer has raised its dividend every year for over a decade, then something changed. Before you coun

The yield you chase to replace a six-figure salary determines far more than how much capital you nee

Pfizer's management remains firmly committed to maintaining the dividend. The company's growth portf

Where you hold a high-yield dividend stock matters almost as much as which one you pick, and for ord

Pfizer, Novartis, Janux Therapeutics and Candel Therapeutics offer varied prostate-cancer exposure,

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to liste

Bank of America Corp DE purchased a new stake in Pfizer Inc. (NYSE: PFE) during the undefined quarte

Pfizer Inc. (PFE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Pfizer NYSE: PFE Chairman and Chief Executive Officer Albert Bourla said the drugmaker has addressed

PFE faces COVID revenue declines and a patent cliff, but new products, acquisitions and a strong pip

Not every high-yield dividend stock belongs in a Roth IRA, but these four generate the kind of ordin

Pfizer's payout looks like a safe harbor in a rough market, but the patent clock is ticking and the

President Trump's Surgeon General nominee Dr. Nicole Saphier disclosed investments in Philip Mor

Medicus Pharma partners with Pfizer to commercialize CD228V in a licensing deal worth over $1 billio

Trump secures drug pricing deals with nine pharma companies as Kennedy reveals intense pressure from

Take-Two Interactive Software, on Aug. 7, reported adjusted earnings were 35 cents per share, toppin

FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligi

2026-2027 COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closel

Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector.

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Arbutus Biopharma (ABUS) stock rises after announcing a $230M stock buyback via a modified Dutch auc

（原标题：辉瑞(PFE.US)海外涨价收益将与美国政府分成：“最惠国”合同曝光，超二十笔交易仍保密） 智通财经APP获悉，据报道，如果辉瑞(PFE.US)能够提高海外药品价格，美国卫生与公众服务部 .

Pfizer Inc. (ISIN US7170811035) stock traded at USD 27.62 on September 19, 2026, with a market capit

Australian workplaces need to move beyond neurodiversity awareness and give managers practical tools

Boebort office rejects ethics allegations: A spokesperson for Rep. Lauren Boebert said there is “zer

Casar calls for review: Rep. Greg Casar said he sent a letter to the Department of Homeland Security

At the close on September 18, 2026, Pfizer stock finished at USD 27.60 on the NYSE, down 0.14 percen

A million dollars sounds like enough to retire on. Whether it actually is depends entirely on what y

Pfizer's rebound is well underway.

【財訊快報／陳孟朔】中國國家主席習近平未來一週訪美之際，北京與華府正敲定隨行的中國企業代表團，比亞迪(002594.SZ)、寧德時代(300750.SZ)、小米集團(01810.HK)、國軒高科(00

【財訊快報／陳孟朔】港股生技類股週一早盤集體逞強，恆生生物科技指數一度大漲4%，主要受到美國川普政府擬對中國生技投資採取較精準而非全面限制的消息激勵。華爾街見聞報導，市場解讀，新規若保留大部分中國新藥